CME Group Inc. Class A (NASDAQ:CME) posted strong Q2 results with record market-data revenue and robust ADV while expanding product lineup—Compute Futures, Single Stock futures settled to closing prices and a sorghum basis contract—amid litigation with the CFTC over crypto perpetuals and a raised BofA price target.
Previous Week Recap
- Record Market-Data Revenue Growth: CME Group (CME) Q2 2026: record market-data revenue $238.1M (+20% YoY); clearing/transaction fees $1.3525B; ADV 29.8M contracts; non-US ADV 9.1M; daily margin efficiencies >$95B
- Sued CFTC Over Crypto Futures: CME Group (CME) sued the CFTC over U.S. crypto perpetual futures, arguing they should be regulated as swaps, and continues litigation to challenge the CFTC’s current treatment.
- Settle Single Stock Futures; Compute Futures: CME Group (CME) to settle Single Stock futures to each stock’s closing price; retail brokers and 35+ partners ready at launch. Also launching Compute Futures tracking NVIDIA H100 GPU rental costs.
- No Demand For Perpetual Futures: CME Group Inc. Class A (CME) CEO Terry Duffy says clients show no demand for perpetual futures after May 2026 approval; perps haven’t appealed to the firm’s core client base.
- Physically Delivered Sorghum Basis Futures: CME Group (CME) plans a physically delivered sorghum basis futures contract vs. CME corn, pending regulatory approval; trading expected to start Aug. 24 to hedge sorghum-to-corn basis risk.
- BOA Raises Price Target To 230: Bank of America lifted its CME Group (CME) price target to $230 from $226. No timing, rationale, or estimate details were provided.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.